Loading...

Financial Summary


AquaBounty Technologies Inc.

AquaBounty Technologies Inc. (AQB)

Healthcare
Neutral
B
Market Info
Financial Info
Financial Modelling
Symbol AQB
Price 1.81$
Beta 1.04
Volume Avrg. 0.13M
Market Cap 0.06B
Shares (2018) 13,028.76K
Last Div 0
Dividend Yield -
DCF Unlevered -
DCF Levered -
ROE -44.68% Strong Sell
ROA -39.46% Strong Sell
Operating Margin -12264.60% Strong Sell
Debt / Equity 15.46% Neutral
P/E - Neutral
P/B 1.28 Strong Buy

Income Statement

Download AQB income statement Download AQB income statement
Year 2011 2012 2013 2014 2015 2016 2017 2018
Earnings Per Share Basic -1.20-1.50-1.20-1.52-1.40-1.60-1.06-0.94
Net Profit Margin -------173.78-122.84
Earnings Per Share Diluted -1.20-1.50-1.20-1.52-1.40-1.60-1.06-0.94
Revenue ------0.050.08
Weighted Average Shares Outstanding --0.300.300.300.308.7713.03
Gross Profit ------0.000.01
Weighted Average Shares Outstanding (Diluted) 3.154.024.024.685.045.308.7713.03
Sales, General and Administrative Expense 3.252.682.983.923.694.645.866.91
Dividend per Share --------
Operating Income -4.41-4.88-4.88-7.14-7.03-8.07-9.23-10.37
Gross Margin ------0.050.08
Earnings before Tax -2.71-4.41-4.69-7.13-7.03-8.47-9.26-10.38
EBITDA Margin -------169.81-112.68
Net Income -2.71-4.41-4.69-7.13-7.03-8.47-9.26-10.38
EBIT Margin -------173.28-122.65
Net Income - Discounted ops --------
Profit Margin -------173.78-122.84
Preferred Dividends --------
Free Cash Flow margin -------0.00-0.00
R&D Expenses 2.171.631.903.213.343.433.373.46
Interest Expense 0.010.000.000.000.000.400.020.02
Earnings Before Tax Margin -------173.78-122.84
Consolidated Income -2.71-4.41-4.69-7.13-7.03-8.47-9.26-10.38
EBIT -4.41-4.69-4.69-7.13-7.03-8.07-9.23-10.37
EBITDA -2.49-4.18-4.54-6.99-6.93-7.91-9.05-9.52
Income Tax Expense --------
Operating Expenses 4.414.884.887.147.038.079.2910.45
Cost of Revenue ------0.050.08
Net Income Com -2.71-4.41-4.69-7.13-7.03-8.47-9.26-10.38
Net Income - Non-Controlling int --------

Balance Sheet Statement

Download AQB income statement Download AQB income statement
Year 2012 2013 2015 2016 2017 2018
Total current liabilities 0.710.700.621.042.720.92
Other Liabilities ------
Long-term debt 2.032.362.072.653.033.52
Cash and cash equivalents 0.351.881.313.320.492.99
Total debt 2.312.362.072.663.083.59
Cash and short-term investments 0.361.891.323.340.513.00
Deferred revenue ------
Inventories ----0.170.08
Tax Liabilities ----0.24-
Goodwill and Intangible Assets 0.290.330.400.390.190.19
Deposit Liabilities ------
Tax assets ------
Total non-current liabilities 2.032.362.072.653.033.52
Total current assets 0.512.191.483.571.393.51
Total liabilities 2.743.062.693.685.754.44
Payables 0.440.700.621.022.670.85
Other comprehensive income -0.66-0.57-0.23-0.29126.72142.71
Short-term investments 0.010.010.010.010.010.01
Retained earnings (deficit) -71.96-76.64-90.80-99.27-108.53-118.91
Property, Plant & Equipment Net 1.131.020.741.7221.8023.72
Total non-current assets 1.451.371.162.1422.3424.16
Other Assets 0.130.220.110.07--
Net Debt 1.940.470.75-0.672.590.60
Investments 0.010.010.010.010.040.03
Total shareholders equity -0.780.50-0.062.0317.9823.23
Total assets 1.963.562.645.7123.7327.67
Long-term investments ----0.020.02
Receivables 0.020.080.040.16--
Short-term debt 0.27--0.020.050.07

Cash Flow Statement

Download AQB income statement Download AQB income statement
Year 2011 2012 2013 2014 2015 2016 2017 2018
Insurance (repayment) of debt --------
Net Cash/Marketcap -0.000.000.000.000.00--
Insurance (buybacks) of shares --------
Depreciation & Amortization -0.210.150.140.110.150.180.84
Dividend payments --------
Operating Cash Flow -4.95-3.72-4.46-6.56-6.75-7.45-9.10-9.82
Acquisitions and disposals --------
Free Cash Flow -5.02-3.77-4.56-6.68-6.82-8.52-27.99-13.83
Net cash flow / Change in cash -0.95-1.281.533.29-3.852.01-2.832.50
Effect of forex changes on cash 0.000.000.00-0.02-0.04-0.010.08-0.05
Financing Cash Flow 0.552.556.1310.023.0410.5425.2416.45
Investment purchases and sales 3.530.00-0.00-----
Capital Expenditure -0.07-0.05-0.10-0.12-0.07-1.0718.894.01
Stock-based compensation 0.250.320.140.270.240.220.120.26
Investing Cash Flow --------

Retained Earning Schedule

Year 2012 2013 2015 2016 2017 2018
Retained Earnings (Previous Year) --72--91-99-109
Net Income -4-5-7-8-9-10
Stock Dividends -68--84---
Divident Paid ------
Retained Earnings -72-77-91-99-109-119

PPE Schedule

Year 2012 2013 2015 2016 2017 2018
Year 201220132015201620172018
Gross PPE -1-1222
Annual Depreciation 1-0121-2
Capital Expenditure -0-0-0-1194
Net PPE 11122224

Intangible and Goodwill Schedule

Year 2012 2013 2015 2016 2017 2018
Intangible and Goodwill (Previous Year) -0-000
New Purchases 0-0----
Intangible and Goodwill 000000
AquaBounty Technologies Inc.

AquaBounty Technologies Inc. (AQB)

1.81
0.09 (+5.23%)

About


Ronald L Stotish
Healthcare
Biotechnology
NASDAQ Capital Market

AquaBounty Technologies Inc is a biotechnology company. The Company is engaged in the business of conducting research and development of the commercial viability of a group of proteins known as antifreeze proteins.